Therefore, further identifying the genetic abnormalities of C-MYC, BCL-2, and BCL-6 in DLBCL is of great significance to guide clinical diagnosis and treatment of DLBCL. The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.